Women taking a new breast cancer drug are living longer than those taking Tamoxifen - the current 'gold standard' treatment. Doctors predict the new drug, Arimidex, will improve long-term survival ...

Women who have no history of breast cancer can take tamoxifen as a way to protect them from getting the disease. This drug reduces the risk of breast cancer in two ways: It blocks estrogen from ...

Weekly administration of prophylactic tamoxifen is much less effective than the standard daily regimen in preventing the adverse breast effects induced by bicalutamide. Bicalutamide monotherapy is ...

Tamoxifen treatment has been linked to an excess risk of nonalcoholic steatohepatitis, which is characterized by inflammation and fatty deposits in the liver. Bruno and colleagues have ...

“It became clear that it was a very well tolerated drug for cancer treatment and there ... “There were trials done and those ...

The key takeaway from this study is that while tamoxifen is a common and important treatment for preventing breast cancer recurrence, nearly 50% of patients don't respond well to it.